Skip to Main Content

Paper Details

Late-Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor-Induced Raynaud's-Like Phenomenon.
Oncologist
16
2020
Raynaud's, Raynaud's-Like Phenomenon, Raynaud's-like, Raynaud's-like phenomenon, advanced non-small lung cancer, anti-, anti-CTLA4, anti-PD1, autoimmune toxicities, cytotoxic T-lymphocyte antigen 4, hypophysitis, immune, irAEs, patient, patients, programmed death 1, woman
Author NameAffiliation
David R KarpUniversity of Texas Southwestern Medical Center
Yang XieUniversity of Texas Southwestern Medical Center
Yang XieHarold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center
Quan-Zhen LiUniversity of Texas Southwestern Medical Center
  • 1 - 4

Datasets

Release 1.2